Patients who have heart failure with reduced ejection fraction (HFrEF) exhibit impaired ventilatory efficiency [i.e. greater ventilatory equivalent for carbon dioxide (V E ∕V CO 2 ) slope] and elevated physiological dead space (V D /V T ). However, the impact of breathing strategy on V D /V T during submaximal exercise in HFrEF is unclear. The HFrEF (n = 9) and control (CTL, n = 9) participants performed constant-load cycling exercise at similar ventilation (V E ). Inspiratory capacity, operating lung volumes and arterial blood gases were measured during submaximal exercise. Arterial blood gases were used to derive V D /V T , alveolar volume, dead space volume, alveolar ventilation and dead space ventilation. During submaximal exercise, HFrEF patients had greaterV E ∕V CO 2 slope and V D /V T than CTL subjects (P = 0.01). At similarV E , HFrEF patients had smaller tidal volumes and alveolar volumes (HFrEF 1.11 ± 0.33 litres versus CTL 1.66 ± 0.37 litres; both P ≤ 0.01), whereas dead space volume was not different (P = 0.47). The augmented breathing frequency in HFrEF patients resulted in greater dead space ventilation compared with CTL subjects (HFrEF 15 ± 4 l min −1 versus CTL 10 ± 5 l min −1 ; P = 0.048). The HFrEF patients exhibited greater increases in expiratory reserve volume and lower inspiratory capacity (as a percentage of predicted) than CTL subjects (both P < 0.05), which were significantly related to V D /V T and alveolar volume in HFrEF patients (all P < 0.03). In HFrEF, the reduced tidal volume and alveolar volume elevate physiological dead space during submaximal exercise, which is worsened in those with the greatest ventilatory constraints. These findings highlight the negative consequences of ventilatory constraints on physiological dead space during submaximal exercise in HFrEF.
INTRODUCTION
Patients who have heart failure with reduced ejection fraction (HFrEF) exhibit impaired ventilatory efficiency during exercise.
Specifically, HFrEF patients have a greater ventilatory equivalent for carbon dioxide (V E ∕V CO 2 ) slope than healthy individuals (Sullivan, Higginbotham, & Cobb, 1988; Wasserman et al., 1997; Wensel et al., 2004; Woods, Olson, Frantz, & Johnson, 2010) , which is predictive of mortality and morbidity (Arena et al., 2007; Arena, Myers, Aslam, Varughese, & Peberdy, 2004) . One of the primary contributors to the elevatedV E ∕V CO 2 slope in HFrEF patients is increased physiological dead space [i.e. the fraction of tidal volume (V T ) consumed by dead space (V D ); V D /V T ], which is influenced by ventilation (V E )-perfusion mismatching and breathing strategy. Previously, Sullivan et al. (1988) found that dead space volume was greater at a given submaximal c 2018 The Authors. Experimental Physiology c 2018 The Physiological Society workload in HFrEF patients compared with healthy adults and surmised that impaired central haemodynamics were responsible for the elevated V D /V T . However, HFrEF patients also had elevateḋ V E compared with healthy adults during submaximal exercise, which might have contributed to the elevated dead space volume. In contrast, Woods et al. (2010) suggested that the characteristic altered breathing strategy [i.e. lower V T and augmented breathing frequency (f B )] of HFrEF patients was the major factor responsible for the elevated V D /V T , probably resulting from the restrictive lung abnormalities in HFrEF (Agostoni, Pellegrino, Conca, Rodarte, & Brusasco, 2002) . A crucial limitation of these previous studies is thatV E was not similar during exercise and, therefore, the possible HFrEF-induced impact on V T , alveolar volume, dead space volume, alveolar ventilation and dead space ventilation is unclear. In this regard, it is possible that the constrained V T reduces alveolar volume in HFrEF, requiring the augmented f B to maintain alveolar ventilation, but consequently, increases dead space ventilation.
Patients with HFrEF present with significant pulmonary abnormalities. For example, HFrEF is associated with restrictive and obstructive lung disorders, bronchial hyperresponsiveness, weakened respiratory muscle strength and reduced lung diffusion capacity, lung compliance and chest wall compliance (Agostoni et al., 2000; Agostoni, Cattadori, Bianchi, & Wasserman, 2003; Cabanes et al., 1989; Cross, Sabapathy, Beck, Morris, & Johnson, 2012; Johnson et al., 2000; Olson, Snyder, & Johnson, 2006) . During exercise, HFrEF patients generally exhibit ventilatory constraints concomitant with the lower V T (Chiari et al., 2013; Cross et al., 2012; Johnson et al., 2000; Laveneziana et al., 2009; O'Donnell, D'Arsigny, Raj, Abdollah, & Webb, 1999; Papazachou et al., 2007) . In fact, a previous study found that partial alleviation of the dynamic hyperinflation [i.e. increased inspiratory capacity (IC) and decreased expiratory reserve volume (ERV)] resulted in increased V T and improvedV E ∕V CO 2 (Laveneziana et al., 2009) 
METHODS

Ethical approval
All aspects of this study were approved by the Mayo Clinic Institutional Review Board (approval no. 09-000032) and conformed to the standards set forth by the latest revision of the Declaration of Helsinki, except for registration in a database. All participants were informed about the experimental procedures and potential risk involved, and provided written and verbal informed consent.
Participants
Nine HFrEF patients and nine healthy matched control (CTL) participants were recruited for this study. The HFrEF patients were recruited from the Mayo Clinic Heart Failure Service and the Cardiovascular Health Clinic. Inclusion criteria for the HFrEF patients included diagnosis of ischaemic or dilated cardiomyopathy with duration of >1 year of symptoms, stable HF symptoms (>3 months), left ventricular ejection fraction ≤35%, body mass index <35 kg m −2 , non-smokers with a smoking history of <15 pack-years, no diagnosis of
New Findings
• What is the central question of this study?
The goal of this study was to investigate the effect of alterations in tidal volume and alveolar volume on the elevated physiological dead space and the contribution of ventilatory constraints thereof in heart failure patients during submaximal exercise.
• What is the main finding and its importance?
We found that physiological dead space was elevated in heart failure via reduced tidal volume and alveolar volume.
Furthermore, the degree of ventilatory constraints was associated with physiological dead space and alveolar volume.
coexisting pulmonary disease and not taking pulmonary medications.
Four HFrEF patients were previous smokers, with a smoking history of 11 ± 3 pack-years. The HFrEF patients performed all testing while remaining on standard pharmacological therapy. The CTL participants were matched for age, height and weight to the HFrEF patients and were free from cardiovascular, pulmonary and muscular diseases.
Experimental design
For this cross-sectional study, participants underwent all protocols and measurements during two study visits. On the first study visit, participants were first familiarized with all experimental measurements and protocols and then performed an incremental exercise test to volitional fatigue to determine peak oxygen uptake (V O 2 peak ). On the second study visit, participants performed constantworkload submaximal exercise at ∼60% of peak workload to matcḣ V E between HFrEF and CTL subjects. Although this was at a lower absolute intensity for the HFrEF group, a previous study showed that the excessive ventilatory response of HFrEF patients resulted in non-significant differences inV E at this relative intensity compared with healthy adults (Olson, Joyner, Eisenach, Curry, & Johnson, 2014) .
For the present experimental design, it was important for HFrEF and CTL subjects to have similarV E so that the components of the alveolar gas equation could be compared appropriately. During the constantload submaximal exercise, participants performed IC manouevres for determination of operating lung volumes, expiratory flow limitation (EFL), and dynamic lung compliance (C L,dyn ), and arterial blood gas sampling occurred for measurement of the partial pressure of carbon dioxide (P aCO 2 ). Hansen, Sue, & Wasserman (1984) .
Peak oxygen uptake
Submaximal exercise
On the second visit, all participants completed a submaximal constantload exercise test. Initially, resting data were collected for 3 min, then the participants cycled at ∼60% of peak workload for 5 min. Towards the end of the submaximal exercise bout, arterial blood gases were sampled and participants performed an IC manouevre. Ventilatory and gas exchange variables were collected at rest and during submaximal exercise, and the 30 s average corresponding to arterial blood gas sampling and the IC manouevre is reported. Furthermore, these resting and exercising data were used to calculate theV E ∕V CO 2 slope for each participant.
Pulmonary function tests
Pulmonary function tests were performed accordingly to established American Thoracic Society/European Respiratory Society guidelines (Miller et al., 2005) . Each participant performed multiple maximal (Knudson, Lebowitz, Holberg, & Burrows, 1983) . Predicted IC was calculated as the predicted total lung capacity minus the predicted functional residual capacity (Stocks & Quanjer, 1995) .
Arterial blood gases
After application of local anaesthetic (1% lidocaine), a 20-gauge Teflon catheter (FA-04020; Arrow International Inc., Reading, PA, USA) was inserted in the radial artery for blood sampling. Arterial blood sampling occurred anaerobically over 10-15 s during submaximal exercise for measurement of P aCO 2 (ABL825 Flex Blood Gas/CO-ox analyzer; Radiometer America Inc., Westlake, OH, USA).
The P aCO 2 was analysed in duplicate, averaged, and temperature corrected at a temperature of 37 • C. We are aware of the different methodologies of temperature correcting blood gases in the literature [i.e. body temperature (oesophageal versus muscle) and standardized temperature]. Previous studies in heart failure patients reporting exercise ventilatory efficiency and blood gases have temperature corrected the blood gases using 37 • C (Agostoni et al., 2002; Olson et al., 2014; Sullivan et al., 1988; Wasserman et al., 1997; Wensel et al., 2004; Woods et al., 2010) . Given that the primary focus of the present study was to examine exercise ventilatory efficiency comprehensively in heart failure patients, we used the standardized temperature consistent with these previous studies. Metabolic, ventilatory and blood gas measurements were used to calculate 
Respiratory pressure
Oesophageal pressure was measured using a latex balloon-tipped catheter (CooperSurgical Inc., Trumbull, CT, USA) inserted via the nares ∼45 cm, after application of local anaesthetic. Correct placement of the balloon (i.e. lower one-third of the oesophagus) was confirmed using the 'occlusion' method (Baydur, Behrakis, Zin, Jaeger, & Milic-Emili, 1982) after inflation of the balloon with 1 ml of air.
Mouth pressure was measured via a lateral port in the mouthpiece.
The catheters were connected to a differential pressure transducer (MP45; Validyne Engineering Corporation, Northridge, CA, USA) and calibrated using a water manometer before each test. 
Ventilatory constraints
Participants performed multiple IC manouevres before exercise to ensure that the manouevres were valid and consistent. At the end of the submaximal exercise bout, participants performed an IC manouevre from end-expiratory lung volume to determine placement of V T . A 'typical' breath was determined if it had similar flow, pressure and volume characteristics to the previous breaths before the IC manouevre. A computer program was used to correct physiological drift as previously described (Dolmage & Goldstein, 2002) . Total lung capacity was assumed not to change significantly during exercise (Johnson, Reddan, Pegelow, Seow, & Dempsey, 1991a; Johnson, Reddan, Seow, & Dempsey, 1991b) . Therefore, ERV was determined by subtracting IC from FVC. Inspiratory reserve volume (IRV) was determined by subtracting the sum of V T and ERV from FVC (Johnson, Weisman, Zeballos, & Beck, 1999) . The change (Δ) in ERV [as a percentage of (% FVC)] was calculated by subtracting exercising ERV (% FVC) from baseline ERV (% FVC). The IC and IC (% predicted) measured during exercise are reported. EFL was quantified as the percentage of the exercising V T that intersected or exceeded the MFVL (Chenoweth, Smith, Ferguson, Downey, & Harms, 2015; Johnson et al., 1999; Smith, Kurti, Meskimen, & Harms, 2017c; Smith, Rosenkranz, & Harms, 2014) . One HFrEF patient did not perform valid IC manouevres and was not included in the ventilatory constraint analysis.
Statistical analyses
Values are reported as the mean ± SD. Statistical analyses were performed using SigmaStat 2.0 (Jandel Scientific, San Rafael, CA, USA) and SAS statistical software v.9.4 (SAS Institute, Cary, NC, USA). Based on previous literature reporting V D /V T in HFrEF and CTL subjects (Woods et al., 2010) , we calculated an effect size (Cohen's d) of 1.97.
Thus, the combination of this effect size with a power of 0.95 and level of 0.05 resulted in sample size calculations of n = 8 per group.
All data were normally distributed as tested by the KolmogorovSmirnov analysis. Participant characteristics and peak exercise data were compared using Student's unpaired t tests. The submaximal exercise data were compared using a one-way ANCOVA, with age entered into the ANCOVA model as a covariate. Relationships were determined via linear regression. Statistical significance was set at P < 0.05.
RESULTS
Participant characteristics
Age, height and weight were not different between HFrEF and CTL subjects ( 
Submaximal exercise responses
During submaximal exercise,V E was not different between groups, but HFrEF patients had a lower V T (HFrEF 1.7 ± 0.4 l versus CTL 2.1 ± 0.3 l, P < 0.01) and greater f B (HFrEF 28 ± 5 breaths min −1 versus CTL 21 ± 3 breaths min −1 , P < 0.01) compared with CTL subjects (Table 3 ). In addition, HFrEF patients had lower submaximal workload (HFrEF 56 ± 17 W versus CTL 108 ± 34 W, P < 0.01) compared with CTL subjects, but greaterV E ∕V CO 2 (HFrEF 39 ± 6 versus CTL 29 ± 6, P = 0.01) andV E ∕V O 2 (HFrEF 35 ± 5 versus CTL 27 ± 4, P < 0.01).
Inspiratory capacity (% predicted) (HFrEF 68 ± 16 versus CTL 83 ± 9, P = 0.03) and V T /FVC (HFrEF 39 ± 8 versus CTL 46 ± 7, P = 0.03) were greater in CTL subjects compared with HFrEF patients, whileV O 2 , IC, ERV, IRV (both % FVC) and C L,dyn were not different between groups.
During submaximal exercise, one of nine HFrEF patients exhibited EFL, whereas no CTL subject exhibited EFL. The HFrEF patients exhibited a greater change (i.e. increase) in ERV (% FVC) from rest to submaximal exercise (HFrEF 17 ± 4 versus CTL 5 ± 9, P = 0.048). The ΔERV and IC (% predicted) were significantly related to postexercise FEV 1 /FVC (r = −0.83 and 0.87; both P < 0.02) and FEF 50 (r = −0.70 and r = 0.87; both P < 0.05) in HFrEF but not CTL subjects (P > 0.30). Furthermore, the ΔERV and IC (% predicted) were significantly related to the change (from pre-to postexercise) in FEV 1 (r = −0.81 and 0.72; both P < 0.05), FEF 75 (r = −0.84 and 0.75; both P < 0.04) and FEF 50 (r = −0.80 and 0.87; P < 0.03) in HFrEF but not CTL subjects (P > 0.12).
TA B L E 3 Submaximal exercise data at similarV E
Parameter
HFrEF CTL P valuė V E (l min −1 ) 4 6 ± 10 45 ± 7 0.82 
Ventilatory efficiency data
At similarV E during submaximal exercise, HFrEF patients had greateṙ V E ∕V CO 2 slope (HFrEF 38 ± 7 versus CTL 27 ± 7, P = 0.01) and V D /V T (HFrEF 0.34 ± 0.08 versus CTL 0.22 ± 0.10, P = 0.04) compared with CTL subjects (Figure 1) . Furthermore, HFrEF patients had lower alveolar volume (HFrEF 1.1 ± 0.3 l versus CTL 1.7 ± 0.4 l, P < 0.01) compared with CTL subjects, whereas dead space volume was not different (P = 0.47; Figure 2 ). The augmented f B in HFrEF resulted in maintained alveolar ventilation compared with CTL subjects (P = 0.36), whereas dead space ventilation was greater in HFrEF patients (HFrEF 15 ± 3 l min −1 versus CTL 10 ± 5 l min −1 , P = 0.048). The HFrEF patients had a lower P aCO 2 compared with CTL subjects, whereas arterial P O 2 , arteriovenous difference in P O 2 and arterial O 2 saturation
were not different between groups (Table 3) . In HFrEF patients, C L,dyn was negatively related to f B ∕V CO 2 and positively related to alveolar volume (r = −0.89, P = 0.04 and r = 0.74, P = 0.04, respectively).
In addition, the ΔERV was positively related to V D /V T and f B ∕V CO 2 and negatively related to alveolar volume during submaximal exercise in HFrEF patients (Figure 3) . Furthermore, IC (% predicted) was negatively related to V D /V T and f B ∕V CO 2 , but positively related to alveolar volume in HFrEF patients (Figure 4 ). These relationships were not present in CTL subjects (Figures 3 and 4) .
DISCUSSION
Major findings
This study was designed to compare the components of the alveolar gas equation at similar exercisingV E in HFrEF and matched healthy adults and to determine whether ventilatory constraints were related to physiological dead space in HFrEF patients. First, we found that
HFrEF patients had lower V T and alveolar volume compared with CTL subjects during submaximal exercise. However, the augmented 
Ventilatory efficiency in HFrEF
Patients with HFrEF exhibit impaired ventilatory efficiency, as indicated by a highV E ∕V CO 2 slope (Olson et al., 2014; Smith, Van Iterson, Johnson, Borlaug, & Olson, 2018b; Sullivan et al., 1988; Wasserman et al., 1997; Wensel et al., 2004; Woods et al., 2010) . Thė V E ∕V CO 2 slope is composed of hyperventilation (P aCO 2 regulation) and
Previous studies have found that both excessive hyperventilation and elevated V D /V T contribute to the ventilatory inefficiency in HFrEF (Woods et al., 2010) . Consistent with these studies, we found that HFrEF patients had a lower P aCO 2 and greater V D /V T during submaximal exercise compared with CTL subjects.
The increased V D /V T in HFrEF has been suggested to be a result of altered breathing strategy and/or ventilation-perfusion heterogeneity. Specifically, ventilation-perfusion heterogeneity has been suggested to contribute significantly to the augmented V D /V T in HFrEF patients during exercise (Sullivan et al., 1988; Wasserman et al., 1997) . In contrast, previous studies have also found that HFrEF patients have a lower V T compared with healthy participants during exercise, and thus breathing strategy has been suggested to make a major contribution to V D /V T (Agostoni et al., 2002; Cross et al., 2012; Johnson et al., 2000; Woods et al., 2010) . However, in the studies that have specifically calculated V D /V T (Woods et al., 2010) , HFrEF patienst had lowerV E , proabably contributing to the lower V T reported. To circumvent this issue in the present study, we specifically compared the groups at similarV E during submaximal exercise. We 
Ventilatory equivalent for carbon dioxide (V E ∕V CO 2 ) slope (a) and physiological dead space (V D /V T ; b) in heart failure patients with reduced ejection fraction (HFrEF) and control subjects (CTL) during exercise. * Significantly different from CTL because they compared HFrEF patients with CTL subjects at matched workload and, as a result, theV E was greater in HFrEF patients during submaximal exercise.
Increased lung stiffness has been suggested as the likely mechanism responsible for this altered breathing strategy (Agostoni et al., 2002; Johnson et al., 2000) . Specifically, C L,dyn has been shown to be lower in HFrEF patients than in healthy adults, and exercising f B ∕V CO 2 is negatively related to resting C L,dyn in HFrEF patients (Agostoni et al., 2002; Cross et al., 2012) . In the present study, C L,dyn was not different between HFrEF and CTL subjects during submaximal exercise. The C L,dyn of the HFrEF patients is consistent, whereas the CTL value is lower than previously reported at a similarV E (Cross et al., 2012) .
Importantly, C L,dyn was significantly related to f B ∕V CO 2 and alveolar volume during submaximal exercise in HFrEF patients, suggesting that alveolar volume was constrained and exercise tachypnoea augmented to the greatest extent in HFrEF patients with the greatest lung stiffness. Possible underlying mechanisms responsible for the restrictive lung abnormalities include cardiomegaly (i.e. competition between lung and cardiac tissue for intrathoracic space), pulmonary congestion and growth of fibrotic tissue (Agostoni et al., 2002 (Agostoni et al., , 2003 Olson & Johnson, 2011; Olson, Beck, & Johnson, 2007) .
Ventilatory constraints in HFrEF
Patients with HFrEF exhibit ventilatory constraints, such as EFL and dynamic hyperinflation, during exercise. Interestingly, we observed a lower occurrence of EFL in HFrEF patients during exercise (one of nine) than some (Cross et al., 2012; Johnson et al., 2000; Laveneziana et al., 2009; O'Donnell et al., 1999) , but not all studies (Chiari et al., 2013) .
This discrepancy in EFL occurrence might be attributable to a different degree of subclinical restrictive pulmonary disease, the severity of constraints. Dynamic hyperinflation has been suggested to occur in response to impending EFL or development of EFL (Babb, 2013) .
Furthermore, a recent study found that heterogeneity existed in dynamic hyperinflation in HFrEF patients who did not exhibit EFL (Chiari et al., 2013) . Specifically, Chiari et al. (2013) found that the HFrEF patients who exhibited dynamic hyperinflation had lower midexpiratory flow rates compared with HFrEF patients who did not exhibit dynamic hyperinflation. In the present study, we found that ΔERV was negatively related to FEV 1 /FVC and FEF 50 and to the degree of bronchodilation. These findings suggest that small airway dysfunction is associated with greater dynamic hyperinflation during submaximal exercise in HFrEF patients, probably resulting from pulmonary congestion and/or airway hyperresponsiveness (Agostoni et al., 2000; Cabanes et al., 1989) . Given that reduced maximal expiratory rates at lower lung volumes will increase the propensity for EFL, it is possible that dynamic hyperinflation occurred because of the impending EFL. Alternatively, respiratory muscle fatigue has also been suggested as a possible mechanism for the smaller IC during exercise in HFrEF. However, this seems unlikely because respiratory muscle fatigue has not been reported in HFrEF patients after incremental exercise (Mancini, Henson, LaManca, & Levine, 1992) and respiratory muscle blood flow is protected in HFrEF patients during exercise (Musch, 1993; Olson et al., 2010; Smith et al., 2017a; Smith, Hageman, Harms, Poole, & Musch, 2017b ).
To date, the studies investigating ventilatory constraints have not investigated the mechanisms underlying ventilatory inefficiency.
Therefore, a secondary purpose of the present study was to determine whether relationships were present between ventilatory constraints to the elevated V D /V T in HFrEF patients. A primary finding of the present study was that increased ERV and IC (% predicted) were significantly related to V D /V T , alveolar volume and breathing strategy.
These findings suggest that alveolar volume (and V T ) is constrained, resulting in a greater V D /V T and f B in HFrEF patients, and to a greater extent in those with the greatest ventilatory constraints. In support for our findings, a previous study found that partial reversal of dynamic hyperinflation during exercise in HFrEF patients via biventricular pacing resulted in increased V T and decreased f B ,V E andV E ∕V CO 2 slope (Laveneziana et al., 2009) . Taken together, these findings suggest that ventilatory constraints in HFrEF patients can significantly impact breathing strategy during exercise, consequently augmenting V D /V T and ventilatory inefficiency.
Methodological considerations
First, although significant relationships were found between dynamic hyperinflation and ventilatory efficiency parameters, future studies implementing an intervention are required to confirm the contribution ) and breathing frequency/carbon dioxide production (f B ∕V CO 2 ; e, f) in heart failure patients with reduced ejection fraction (HFrEF) and control subjects (CTL), respectively, during exercise. n = 8 because the inspiratory capacity manoeuvre from one HFrEF patient was not valid (see Methods) of dynamic hyperinflation to V D /V T in HFrEF. Second, the purpose of the present study was to compare the components of the alveolar gas equation at similarV E . Future studies are necessary to determine whether the differences presented herein are present at differenṫ V E during exercise. Third, although our study was designed to have the power to detect statistical significance, we acknowledge that the sample size is relatively small owing to the invasive nature of the techniques. Studies with larger sample sizes might be necessary to confirm our findings. Finally, total lung capacity and residual volume were not measured, which would have provided valuable insight regarding the absolute lung volumes of the HFrEF and CTL subjects during exercise. ) and breathing frequency/carbon dioxide production (f B ∕V CO 2 ; e, f) in heart failure patients with reduced ejection fraction (HFrEF) and control subjects (CTL), respectively during exercise. n = 8 because the IC manoeuvre from one HFrEF patient was not valid (see Methods)
CONCLUSIONS
In 
